nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—CYP1A2—Dacarbazine—muscle cancer	0.197	0.567	CbGbCtD
Betaxolol—CYP1A2—Etoposide—muscle cancer	0.0965	0.277	CbGbCtD
Betaxolol—CYP2D6—Doxorubicin—muscle cancer	0.0542	0.156	CbGbCtD
Betaxolol—Pain—Dactinomycin—muscle cancer	0.00153	0.00235	CcSEcCtD
Betaxolol—Vascular purpura—Doxorubicin—muscle cancer	0.00153	0.00235	CcSEcCtD
Betaxolol—Muscle spasms—Etoposide—muscle cancer	0.00153	0.00234	CcSEcCtD
Betaxolol—Anorexia—Vincristine—muscle cancer	0.00153	0.00234	CcSEcCtD
Betaxolol—Eczema—Doxorubicin—muscle cancer	0.00152	0.00233	CcSEcCtD
Betaxolol—Eye pain—Doxorubicin—muscle cancer	0.00152	0.00232	CcSEcCtD
Betaxolol—Mood swings—Methotrexate—muscle cancer	0.0015	0.0023	CcSEcCtD
Betaxolol—Hypotension—Vincristine—muscle cancer	0.0015	0.00229	CcSEcCtD
Betaxolol—Ataxia—Methotrexate—muscle cancer	0.00149	0.00228	CcSEcCtD
Betaxolol—Feeling abnormal—Dactinomycin—muscle cancer	0.00148	0.00226	CcSEcCtD
Betaxolol—Ill-defined disorder—Etoposide—muscle cancer	0.00147	0.00226	CcSEcCtD
Betaxolol—Anaemia—Etoposide—muscle cancer	0.00147	0.00225	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00146	0.00224	CcSEcCtD
Betaxolol—Increased appetite—Doxorubicin—muscle cancer	0.00146	0.00223	CcSEcCtD
Betaxolol—Insomnia—Vincristine—muscle cancer	0.00145	0.00222	CcSEcCtD
Betaxolol—Renal impairment—Doxorubicin—muscle cancer	0.00144	0.0022	CcSEcCtD
Betaxolol—Paraesthesia—Vincristine—muscle cancer	0.00144	0.0022	CcSEcCtD
Betaxolol—Malaise—Etoposide—muscle cancer	0.00143	0.0022	CcSEcCtD
Betaxolol—Breast disorder—Methotrexate—muscle cancer	0.00143	0.00219	CcSEcCtD
Betaxolol—Vertigo—Etoposide—muscle cancer	0.00143	0.00219	CcSEcCtD
Betaxolol—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00142	0.00218	CcSEcCtD
Betaxolol—Purpura—Doxorubicin—muscle cancer	0.00142	0.00218	CcSEcCtD
Betaxolol—Body temperature increased—Dactinomycin—muscle cancer	0.00142	0.00217	CcSEcCtD
Betaxolol—Hypoglycaemia—Doxorubicin—muscle cancer	0.0014	0.00215	CcSEcCtD
Betaxolol—Cardiac failure—Doxorubicin—muscle cancer	0.0014	0.00215	CcSEcCtD
Betaxolol—Loss of consciousness—Etoposide—muscle cancer	0.0014	0.00214	CcSEcCtD
Betaxolol—Lethargy—Doxorubicin—muscle cancer	0.0014	0.00214	CcSEcCtD
Betaxolol—Decreased appetite—Vincristine—muscle cancer	0.00139	0.00213	CcSEcCtD
Betaxolol—Cough—Etoposide—muscle cancer	0.00139	0.00213	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Vincristine—muscle cancer	0.00138	0.00212	CcSEcCtD
Betaxolol—Fatigue—Vincristine—muscle cancer	0.00138	0.00212	CcSEcCtD
Betaxolol—Constipation—Vincristine—muscle cancer	0.00137	0.0021	CcSEcCtD
Betaxolol—Pain—Vincristine—muscle cancer	0.00137	0.0021	CcSEcCtD
Betaxolol—Osteoarthritis—Doxorubicin—muscle cancer	0.00137	0.0021	CcSEcCtD
Betaxolol—Asthma—Methotrexate—muscle cancer	0.00137	0.00209	CcSEcCtD
Betaxolol—Chest pain—Etoposide—muscle cancer	0.00135	0.00207	CcSEcCtD
Betaxolol—Affect lability—Doxorubicin—muscle cancer	0.00135	0.00207	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00134	0.00206	CcSEcCtD
Betaxolol—Discomfort—Etoposide—muscle cancer	0.00134	0.00205	CcSEcCtD
Betaxolol—Hypersensitivity—Dactinomycin—muscle cancer	0.00132	0.00202	CcSEcCtD
Betaxolol—Confusional state—Etoposide—muscle cancer	0.00131	0.002	CcSEcCtD
Betaxolol—Mood swings—Doxorubicin—muscle cancer	0.0013	0.00199	CcSEcCtD
Betaxolol—Infection—Etoposide—muscle cancer	0.00129	0.00198	CcSEcCtD
Betaxolol—Ataxia—Doxorubicin—muscle cancer	0.00129	0.00197	CcSEcCtD
Betaxolol—Asthenia—Dactinomycin—muscle cancer	0.00128	0.00197	CcSEcCtD
Betaxolol—Dysuria—Methotrexate—muscle cancer	0.00128	0.00196	CcSEcCtD
Betaxolol—Thrombocytopenia—Etoposide—muscle cancer	0.00127	0.00195	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00127	0.00195	CcSEcCtD
Betaxolol—Tachycardia—Etoposide—muscle cancer	0.00127	0.00194	CcSEcCtD
Betaxolol—Body temperature increased—Vincristine—muscle cancer	0.00126	0.00194	CcSEcCtD
Betaxolol—Skin disorder—Etoposide—muscle cancer	0.00126	0.00193	CcSEcCtD
Betaxolol—Erectile dysfunction—Methotrexate—muscle cancer	0.00126	0.00193	CcSEcCtD
Betaxolol—Hyperhidrosis—Etoposide—muscle cancer	0.00125	0.00192	CcSEcCtD
Betaxolol—Hypokalaemia—Doxorubicin—muscle cancer	0.00124	0.00191	CcSEcCtD
Betaxolol—Breast disorder—Doxorubicin—muscle cancer	0.00124	0.0019	CcSEcCtD
Betaxolol—Anorexia—Etoposide—muscle cancer	0.00124	0.0019	CcSEcCtD
Betaxolol—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00123	0.00189	CcSEcCtD
Betaxolol—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00123	0.00189	CcSEcCtD
Betaxolol—Diarrhoea—Dactinomycin—muscle cancer	0.00123	0.00188	CcSEcCtD
Betaxolol—Pneumonia—Methotrexate—muscle cancer	0.00122	0.00188	CcSEcCtD
Betaxolol—Nasopharyngitis—Doxorubicin—muscle cancer	0.00122	0.00188	CcSEcCtD
Betaxolol—Infestation NOS—Methotrexate—muscle cancer	0.00122	0.00187	CcSEcCtD
Betaxolol—Infestation—Methotrexate—muscle cancer	0.00122	0.00187	CcSEcCtD
Betaxolol—Depression—Methotrexate—muscle cancer	0.00121	0.00186	CcSEcCtD
Betaxolol—Hypotension—Etoposide—muscle cancer	0.00121	0.00186	CcSEcCtD
Betaxolol—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00121	0.00185	CcSEcCtD
Betaxolol—Stomatitis—Methotrexate—muscle cancer	0.00119	0.00182	CcSEcCtD
Betaxolol—Conjunctivitis—Methotrexate—muscle cancer	0.00118	0.00182	CcSEcCtD
Betaxolol—Asthma—Doxorubicin—muscle cancer	0.00118	0.00181	CcSEcCtD
Betaxolol—Dysphagia—Doxorubicin—muscle cancer	0.00118	0.00181	CcSEcCtD
Betaxolol—Influenza—Doxorubicin—muscle cancer	0.00118	0.00181	CcSEcCtD
Betaxolol—Hypersensitivity—Vincristine—muscle cancer	0.00118	0.00181	CcSEcCtD
Betaxolol—Sweating—Methotrexate—muscle cancer	0.00117	0.00179	CcSEcCtD
Betaxolol—Paraesthesia—Etoposide—muscle cancer	0.00116	0.00179	CcSEcCtD
Betaxolol—Dyspnoea—Etoposide—muscle cancer	0.00116	0.00177	CcSEcCtD
Betaxolol—Angina pectoris—Doxorubicin—muscle cancer	0.00115	0.00177	CcSEcCtD
Betaxolol—Epistaxis—Methotrexate—muscle cancer	0.00115	0.00176	CcSEcCtD
Betaxolol—Asthenia—Vincristine—muscle cancer	0.00115	0.00176	CcSEcCtD
Betaxolol—Vomiting—Dactinomycin—muscle cancer	0.00114	0.00175	CcSEcCtD
Betaxolol—Bronchitis—Doxorubicin—muscle cancer	0.00114	0.00174	CcSEcCtD
Betaxolol—Agranulocytosis—Methotrexate—muscle cancer	0.00114	0.00174	CcSEcCtD
Betaxolol—Rash—Dactinomycin—muscle cancer	0.00113	0.00173	CcSEcCtD
Betaxolol—Decreased appetite—Etoposide—muscle cancer	0.00113	0.00173	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Etoposide—muscle cancer	0.00112	0.00172	CcSEcCtD
Betaxolol—Fatigue—Etoposide—muscle cancer	0.00112	0.00171	CcSEcCtD
Betaxolol—Pain—Etoposide—muscle cancer	0.00111	0.0017	CcSEcCtD
Betaxolol—Constipation—Etoposide—muscle cancer	0.00111	0.0017	CcSEcCtD
Betaxolol—Dysuria—Doxorubicin—muscle cancer	0.00111	0.0017	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.0011	0.00169	CcSEcCtD
Betaxolol—Diarrhoea—Vincristine—muscle cancer	0.00109	0.00168	CcSEcCtD
Betaxolol—Pharyngitis—Methotrexate—muscle cancer	0.00108	0.00166	CcSEcCtD
Betaxolol—Weight increased—Doxorubicin—muscle cancer	0.00108	0.00165	CcSEcCtD
Betaxolol—Weight decreased—Doxorubicin—muscle cancer	0.00107	0.00164	CcSEcCtD
Betaxolol—Feeling abnormal—Etoposide—muscle cancer	0.00107	0.00164	CcSEcCtD
Betaxolol—Hyperglycaemia—Doxorubicin—muscle cancer	0.00107	0.00164	CcSEcCtD
Betaxolol—Nausea—Dactinomycin—muscle cancer	0.00106	0.00163	CcSEcCtD
Betaxolol—Pneumonia—Doxorubicin—muscle cancer	0.00106	0.00163	CcSEcCtD
Betaxolol—Dizziness—Vincristine—muscle cancer	0.00106	0.00162	CcSEcCtD
Betaxolol—Infestation NOS—Doxorubicin—muscle cancer	0.00105	0.00162	CcSEcCtD
Betaxolol—Infestation—Doxorubicin—muscle cancer	0.00105	0.00162	CcSEcCtD
Betaxolol—Visual impairment—Methotrexate—muscle cancer	0.00105	0.00162	CcSEcCtD
Betaxolol—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00103	0.00158	CcSEcCtD
Betaxolol—Urticaria—Etoposide—muscle cancer	0.00103	0.00158	CcSEcCtD
Betaxolol—Stomatitis—Doxorubicin—muscle cancer	0.00103	0.00158	CcSEcCtD
Betaxolol—Body temperature increased—Etoposide—muscle cancer	0.00102	0.00157	CcSEcCtD
Betaxolol—Conjunctivitis—Doxorubicin—muscle cancer	0.00102	0.00157	CcSEcCtD
Betaxolol—Eye disorder—Methotrexate—muscle cancer	0.00102	0.00157	CcSEcCtD
Betaxolol—Tinnitus—Methotrexate—muscle cancer	0.00102	0.00156	CcSEcCtD
Betaxolol—Vomiting—Vincristine—muscle cancer	0.00102	0.00156	CcSEcCtD
Betaxolol—Cardiac disorder—Methotrexate—muscle cancer	0.00101	0.00156	CcSEcCtD
Betaxolol—Sweating—Doxorubicin—muscle cancer	0.00101	0.00155	CcSEcCtD
Betaxolol—Rash—Vincristine—muscle cancer	0.00101	0.00155	CcSEcCtD
Betaxolol—Dermatitis—Vincristine—muscle cancer	0.00101	0.00155	CcSEcCtD
Betaxolol—Headache—Vincristine—muscle cancer	0.001	0.00154	CcSEcCtD
Betaxolol—Epistaxis—Doxorubicin—muscle cancer	0.000994	0.00153	CcSEcCtD
Betaxolol—Angiopathy—Methotrexate—muscle cancer	0.000991	0.00152	CcSEcCtD
Betaxolol—Sinusitis—Doxorubicin—muscle cancer	0.000989	0.00152	CcSEcCtD
Betaxolol—Immune system disorder—Methotrexate—muscle cancer	0.000987	0.00151	CcSEcCtD
Betaxolol—Mediastinal disorder—Methotrexate—muscle cancer	0.000985	0.00151	CcSEcCtD
Betaxolol—Agranulocytosis—Doxorubicin—muscle cancer	0.000984	0.00151	CcSEcCtD
Betaxolol—Chills—Methotrexate—muscle cancer	0.000981	0.0015	CcSEcCtD
Betaxolol—Alopecia—Methotrexate—muscle cancer	0.000966	0.00148	CcSEcCtD
Betaxolol—Bradycardia—Doxorubicin—muscle cancer	0.000963	0.00148	CcSEcCtD
Betaxolol—Mental disorder—Methotrexate—muscle cancer	0.000957	0.00147	CcSEcCtD
Betaxolol—Hypersensitivity—Etoposide—muscle cancer	0.000955	0.00146	CcSEcCtD
Betaxolol—Erythema—Methotrexate—muscle cancer	0.000951	0.00146	CcSEcCtD
Betaxolol—Malnutrition—Methotrexate—muscle cancer	0.000951	0.00146	CcSEcCtD
Betaxolol—Nausea—Vincristine—muscle cancer	0.00095	0.00146	CcSEcCtD
Betaxolol—Rhinitis—Doxorubicin—muscle cancer	0.000949	0.00146	CcSEcCtD
Betaxolol—Hypoaesthesia—Doxorubicin—muscle cancer	0.000941	0.00144	CcSEcCtD
Betaxolol—Pharyngitis—Doxorubicin—muscle cancer	0.000939	0.00144	CcSEcCtD
Betaxolol—Dysgeusia—Methotrexate—muscle cancer	0.000932	0.00143	CcSEcCtD
Betaxolol—Asthenia—Etoposide—muscle cancer	0.00093	0.00143	CcSEcCtD
Betaxolol—Pruritus—Etoposide—muscle cancer	0.000917	0.00141	CcSEcCtD
Betaxolol—Visual impairment—Doxorubicin—muscle cancer	0.000912	0.0014	CcSEcCtD
Betaxolol—Vision blurred—Methotrexate—muscle cancer	0.000897	0.00138	CcSEcCtD
Betaxolol—Diarrhoea—Etoposide—muscle cancer	0.000887	0.00136	CcSEcCtD
Betaxolol—Eye disorder—Doxorubicin—muscle cancer	0.000884	0.00136	CcSEcCtD
Betaxolol—Ill-defined disorder—Methotrexate—muscle cancer	0.000883	0.00135	CcSEcCtD
Betaxolol—Tinnitus—Doxorubicin—muscle cancer	0.000882	0.00135	CcSEcCtD
Betaxolol—Anaemia—Methotrexate—muscle cancer	0.000879	0.00135	CcSEcCtD
Betaxolol—Cardiac disorder—Doxorubicin—muscle cancer	0.000878	0.00135	CcSEcCtD
Betaxolol—Flushing—Doxorubicin—muscle cancer	0.000878	0.00135	CcSEcCtD
Betaxolol—Angiopathy—Doxorubicin—muscle cancer	0.000858	0.00132	CcSEcCtD
Betaxolol—Malaise—Methotrexate—muscle cancer	0.000858	0.00132	CcSEcCtD
Betaxolol—Dizziness—Etoposide—muscle cancer	0.000857	0.00131	CcSEcCtD
Betaxolol—Immune system disorder—Doxorubicin—muscle cancer	0.000855	0.00131	CcSEcCtD
Betaxolol—Vertigo—Methotrexate—muscle cancer	0.000855	0.00131	CcSEcCtD
Betaxolol—Mediastinal disorder—Doxorubicin—muscle cancer	0.000853	0.00131	CcSEcCtD
Betaxolol—Chills—Doxorubicin—muscle cancer	0.000849	0.0013	CcSEcCtD
Betaxolol—Arrhythmia—Doxorubicin—muscle cancer	0.000845	0.0013	CcSEcCtD
Betaxolol—Alopecia—Doxorubicin—muscle cancer	0.000836	0.00128	CcSEcCtD
Betaxolol—Cough—Methotrexate—muscle cancer	0.00083	0.00127	CcSEcCtD
Betaxolol—Mental disorder—Doxorubicin—muscle cancer	0.000829	0.00127	CcSEcCtD
Betaxolol—Vomiting—Etoposide—muscle cancer	0.000824	0.00126	CcSEcCtD
Betaxolol—Erythema—Doxorubicin—muscle cancer	0.000824	0.00126	CcSEcCtD
Betaxolol—Malnutrition—Doxorubicin—muscle cancer	0.000824	0.00126	CcSEcCtD
Betaxolol—Rash—Etoposide—muscle cancer	0.000817	0.00125	CcSEcCtD
Betaxolol—Dermatitis—Etoposide—muscle cancer	0.000816	0.00125	CcSEcCtD
Betaxolol—Headache—Etoposide—muscle cancer	0.000812	0.00125	CcSEcCtD
Betaxolol—Arthralgia—Methotrexate—muscle cancer	0.00081	0.00124	CcSEcCtD
Betaxolol—Chest pain—Methotrexate—muscle cancer	0.00081	0.00124	CcSEcCtD
Betaxolol—Myalgia—Methotrexate—muscle cancer	0.00081	0.00124	CcSEcCtD
Betaxolol—Tension—Doxorubicin—muscle cancer	0.000808	0.00124	CcSEcCtD
Betaxolol—Dysgeusia—Doxorubicin—muscle cancer	0.000807	0.00124	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000804	0.00123	CcSEcCtD
Betaxolol—Discomfort—Methotrexate—muscle cancer	0.0008	0.00123	CcSEcCtD
Betaxolol—Nervousness—Doxorubicin—muscle cancer	0.0008	0.00123	CcSEcCtD
Betaxolol—Muscle spasms—Doxorubicin—muscle cancer	0.000792	0.00121	CcSEcCtD
Betaxolol—Confusional state—Methotrexate—muscle cancer	0.000783	0.0012	CcSEcCtD
Betaxolol—Vision blurred—Doxorubicin—muscle cancer	0.000776	0.00119	CcSEcCtD
Betaxolol—Infection—Methotrexate—muscle cancer	0.000771	0.00118	CcSEcCtD
Betaxolol—Nausea—Etoposide—muscle cancer	0.00077	0.00118	CcSEcCtD
Betaxolol—Ill-defined disorder—Doxorubicin—muscle cancer	0.000764	0.00117	CcSEcCtD
Betaxolol—Nervous system disorder—Methotrexate—muscle cancer	0.000761	0.00117	CcSEcCtD
Betaxolol—Anaemia—Doxorubicin—muscle cancer	0.000761	0.00117	CcSEcCtD
Betaxolol—Thrombocytopenia—Methotrexate—muscle cancer	0.00076	0.00117	CcSEcCtD
Betaxolol—Skin disorder—Methotrexate—muscle cancer	0.000754	0.00116	CcSEcCtD
Betaxolol—Hyperhidrosis—Methotrexate—muscle cancer	0.000751	0.00115	CcSEcCtD
Betaxolol—Malaise—Doxorubicin—muscle cancer	0.000743	0.00114	CcSEcCtD
Betaxolol—Vertigo—Doxorubicin—muscle cancer	0.00074	0.00114	CcSEcCtD
Betaxolol—Anorexia—Methotrexate—muscle cancer	0.00074	0.00114	CcSEcCtD
Betaxolol—Syncope—Doxorubicin—muscle cancer	0.000739	0.00113	CcSEcCtD
Betaxolol—Palpitations—Doxorubicin—muscle cancer	0.000728	0.00112	CcSEcCtD
Betaxolol—Hypotension—Methotrexate—muscle cancer	0.000725	0.00111	CcSEcCtD
Betaxolol—Loss of consciousness—Doxorubicin—muscle cancer	0.000724	0.00111	CcSEcCtD
Betaxolol—Cough—Doxorubicin—muscle cancer	0.000719	0.0011	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000707	0.00109	CcSEcCtD
Betaxolol—Insomnia—Methotrexate—muscle cancer	0.000702	0.00108	CcSEcCtD
Betaxolol—Arthralgia—Doxorubicin—muscle cancer	0.000701	0.00108	CcSEcCtD
Betaxolol—Myalgia—Doxorubicin—muscle cancer	0.000701	0.00108	CcSEcCtD
Betaxolol—Chest pain—Doxorubicin—muscle cancer	0.000701	0.00108	CcSEcCtD
Betaxolol—Anxiety—Doxorubicin—muscle cancer	0.000699	0.00107	CcSEcCtD
Betaxolol—Paraesthesia—Methotrexate—muscle cancer	0.000697	0.00107	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000696	0.00107	CcSEcCtD
Betaxolol—Discomfort—Doxorubicin—muscle cancer	0.000693	0.00106	CcSEcCtD
Betaxolol—Dyspnoea—Methotrexate—muscle cancer	0.000692	0.00106	CcSEcCtD
Betaxolol—Dry mouth—Doxorubicin—muscle cancer	0.000686	0.00105	CcSEcCtD
Betaxolol—Dyspepsia—Methotrexate—muscle cancer	0.000683	0.00105	CcSEcCtD
Betaxolol—Confusional state—Doxorubicin—muscle cancer	0.000678	0.00104	CcSEcCtD
Betaxolol—Decreased appetite—Methotrexate—muscle cancer	0.000675	0.00104	CcSEcCtD
Betaxolol—Oedema—Doxorubicin—muscle cancer	0.000672	0.00103	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00067	0.00103	CcSEcCtD
Betaxolol—Fatigue—Methotrexate—muscle cancer	0.000669	0.00103	CcSEcCtD
Betaxolol—Infection—Doxorubicin—muscle cancer	0.000668	0.00102	CcSEcCtD
Betaxolol—Pain—Methotrexate—muscle cancer	0.000664	0.00102	CcSEcCtD
Betaxolol—Shock—Doxorubicin—muscle cancer	0.000661	0.00101	CcSEcCtD
Betaxolol—Nervous system disorder—Doxorubicin—muscle cancer	0.000659	0.00101	CcSEcCtD
Betaxolol—Thrombocytopenia—Doxorubicin—muscle cancer	0.000658	0.00101	CcSEcCtD
Betaxolol—Tachycardia—Doxorubicin—muscle cancer	0.000656	0.00101	CcSEcCtD
Betaxolol—Skin disorder—Doxorubicin—muscle cancer	0.000653	0.001	CcSEcCtD
Betaxolol—Hyperhidrosis—Doxorubicin—muscle cancer	0.00065	0.000997	CcSEcCtD
Betaxolol—Anorexia—Doxorubicin—muscle cancer	0.000641	0.000983	CcSEcCtD
Betaxolol—Feeling abnormal—Methotrexate—muscle cancer	0.00064	0.000981	CcSEcCtD
Betaxolol—Hypotension—Doxorubicin—muscle cancer	0.000628	0.000964	CcSEcCtD
Betaxolol—Urticaria—Methotrexate—muscle cancer	0.000617	0.000946	CcSEcCtD
Betaxolol—Body temperature increased—Methotrexate—muscle cancer	0.000614	0.000941	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000612	0.00094	CcSEcCtD
Betaxolol—Insomnia—Doxorubicin—muscle cancer	0.000608	0.000933	CcSEcCtD
Betaxolol—Paraesthesia—Doxorubicin—muscle cancer	0.000604	0.000926	CcSEcCtD
Betaxolol—Dyspnoea—Doxorubicin—muscle cancer	0.000599	0.000919	CcSEcCtD
Betaxolol—Dyspepsia—Doxorubicin—muscle cancer	0.000592	0.000908	CcSEcCtD
Betaxolol—Decreased appetite—Doxorubicin—muscle cancer	0.000584	0.000896	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00058	0.00089	CcSEcCtD
Betaxolol—Fatigue—Doxorubicin—muscle cancer	0.00058	0.000889	CcSEcCtD
Betaxolol—Pain—Doxorubicin—muscle cancer	0.000575	0.000882	CcSEcCtD
Betaxolol—Constipation—Doxorubicin—muscle cancer	0.000575	0.000882	CcSEcCtD
Betaxolol—Hypersensitivity—Methotrexate—muscle cancer	0.000572	0.000877	CcSEcCtD
Betaxolol—Asthenia—Methotrexate—muscle cancer	0.000557	0.000854	CcSEcCtD
Betaxolol—Feeling abnormal—Doxorubicin—muscle cancer	0.000554	0.00085	CcSEcCtD
Betaxolol—Pruritus—Methotrexate—muscle cancer	0.000549	0.000843	CcSEcCtD
Betaxolol—Urticaria—Doxorubicin—muscle cancer	0.000534	0.000819	CcSEcCtD
Betaxolol—Body temperature increased—Doxorubicin—muscle cancer	0.000531	0.000815	CcSEcCtD
Betaxolol—Diarrhoea—Methotrexate—muscle cancer	0.000531	0.000815	CcSEcCtD
Betaxolol—Dizziness—Methotrexate—muscle cancer	0.000513	0.000788	CcSEcCtD
Betaxolol—Hypersensitivity—Doxorubicin—muscle cancer	0.000495	0.00076	CcSEcCtD
Betaxolol—Vomiting—Methotrexate—muscle cancer	0.000494	0.000757	CcSEcCtD
Betaxolol—Rash—Methotrexate—muscle cancer	0.00049	0.000751	CcSEcCtD
Betaxolol—Dermatitis—Methotrexate—muscle cancer	0.000489	0.00075	CcSEcCtD
Betaxolol—Headache—Methotrexate—muscle cancer	0.000486	0.000746	CcSEcCtD
Betaxolol—Asthenia—Doxorubicin—muscle cancer	0.000482	0.00074	CcSEcCtD
Betaxolol—Pruritus—Doxorubicin—muscle cancer	0.000476	0.00073	CcSEcCtD
Betaxolol—Nausea—Methotrexate—muscle cancer	0.000461	0.000707	CcSEcCtD
Betaxolol—Diarrhoea—Doxorubicin—muscle cancer	0.00046	0.000706	CcSEcCtD
Betaxolol—Dizziness—Doxorubicin—muscle cancer	0.000445	0.000682	CcSEcCtD
Betaxolol—Vomiting—Doxorubicin—muscle cancer	0.000427	0.000656	CcSEcCtD
Betaxolol—Rash—Doxorubicin—muscle cancer	0.000424	0.00065	CcSEcCtD
Betaxolol—Dermatitis—Doxorubicin—muscle cancer	0.000423	0.00065	CcSEcCtD
Betaxolol—Headache—Doxorubicin—muscle cancer	0.000421	0.000646	CcSEcCtD
Betaxolol—Nausea—Doxorubicin—muscle cancer	0.000399	0.000613	CcSEcCtD
Betaxolol—Chlorphenesin—PTGS2—muscle cancer	0.000135	1	CrCbGaD
